FIELD: biotechnology.
SUBSTANCE: invention relates to a recombinant strain of Escherichia coli BL21 (DE3; pQE-Nit2). This strain was obtained by transforming the Escherichia coli strain BL21 (DE3) by the plasmid construct pQE-Nit2, which is under the control of the T5 phage promoter and is designed to produce human ω-amidase (Nit2) when cultivated on nutrient media based on peptone, yeast extract and glucose. The peculiarity of the Nit2 gene in the pQE-Nit2 construct is optimized codon composition, as well as presence of an artificially introduced 6His- affinity tag immediately after the initiator codon ATG (Met), which allows one-step product purification by metal-affinity chromatography on Ni-NTA-agarose.
EFFECT: invention allows to obtain human ω-amidase with an elevated yield.
2 dwg, 1 tbl, 6 ex
Authors
Dates
2018-01-24—Published
2016-06-09—Filed